시장보고서
상품코드
1867531

세계의 경두개 자기 자극(TMS) 코일 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

TMS (Transcranial Magnetic Stimulation) Coil - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 경두개 자기 자극(TMS) 코일 시장 규모는 2024년에 2,990만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 16.0%로 성장하여 2031년까지 8,540만 달러에 이를 것으로 예측됩니다.

본 보고서는 경두개 자기자극(TMS) 코일에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축 등을 종합적으로 평가했습니다.

경두개 자기자극(TMS) 코일은 TMS 장치의 핵심 부품으로, 빠르게 변화하는 자기장을 발생시켜 피질 뉴런에 전류를 유도하여 비침습적으로 뇌 활동을 조절하는 역할을 합니다. 일반적으로 코일 형태로 감긴 전도성 구리선으로 제조되는 TMS 코일은 8자형, 원형, H자형 등 다양한 형태가 있으며, 각각 초점 깊이와 자극 깊이가 다릅니다. TMS 코일은 정신과 치료(예: 우울증, 불안장애), 신경 재활(예: 뇌졸중 후 회복, 파킨슨병), 신경과학 연구에 널리 활용되고 있습니다. 정밀의료, 개인맞춤형 치료, 정신건강에 대한 수요가 증가함에 따라 TMS 코일은 학술연구기관에서 일상적인 임상현장으로의 전환이 진행되고 있으며, 차세대 신경조절시스템의 중요한 기술기반이 되고 있습니다. 2024년 세계 경두개 자기자극(TMS) 코일 생산량은 약 5,688대, 세계 평균 시장 가격은 대당 약 5,270달러에 달했습니다.

세계적으로 정신질환의 유병률 증가와 비약물요법에 대한 수요가 증가함에 따라 TMS 기술은 임상 및 연구 분야에서 빠르게 확산되고 있습니다. TMS 장비의 핵심 부품인 코일의 성능과 비용 효율성은 치료 결과와 장비 도입에 있어 매우 중요합니다. 뇌심부자극과 다채널 표적화 기능을 갖춘 차세대 코일의 지속적인 등장으로 치료 적용 범위가 우울증에서 알츠하이머병, 자폐증, 만성통증으로 확대되고 있습니다. 한편, 미국, EU 등 선진시장의 유리한 리베이트 정책은 병원, 정신과, 재활센터 등의 TMS 장비 조달을 촉진하고, 코일에 대한 업스트림 수요를 크게 증가시키고 있습니다.

전자기 에너지 변환 장치인 TMS 코일은 복잡한 설계, 내열성 요구 사항, 생산 일관성 확보 문제 등 높은 기술적 장벽에 직면해 있습니다. 전 세계적으로 대부분의 TMS 장비 제조업체는 자체 또는 폐쇄형 코일 공급망에 의존하고 있으며, 독립 코일 벤더의 진입 기회는 제한적입니다. TMS 코일은 고빈도 소모품으로 교체주기 및 사용기준이 크게 달라 실제 수요와 시장 규모 예측에 괴리가 발생하고 있습니다. 또한, 전 세계적으로 의료기기 규제가 강화됨에 따라 인증 주기가 길어지고 엄격한 검증 프로토콜과 같은 장벽도 존재합니다.

TMS의 응용 분야는 정신의학(주로 주요 우울장애)에서 재활의료, 통증관리, 소아신경질환으로 빠르게 확대되고 있습니다. 환자 중심의 치료 모델은 맞춤형 코일 설계와 개별화된 자극 프로토콜에 대한 수요를 주도하고 있으며, 이는 기기 제조업체들 간의 중요한 차별화 요소로 작용하고 있습니다. 휴대용 및 가정용 TMS 기기의 등장으로 소형 경량 코일에 대한 수요가 확대되고 있습니다. 연구기관, 스타트업 기업, 외래 진료 체인 등 새로운 구매층이 시장 상황을 재구성하고 TMS 코일 공급업체에게 새로운 성장 가능성을 열어주고 있습니다.

이 보고서는 경두개 자기자극(TMS) 코일 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

TMS(경두개 자기자극(TMS) 코일 시장 규모 추정 및 예측은 판매량(1,000대) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도로 하여 2020년부터 2031년까지의 과거 데이터와 예측 데이터를 포함하고 있습니다. 정량적, 정성적 분석을 통해 독자들이 TMS(경두개 자기자극) 코일 관련 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

  • Magstim
  • Neuronetics
  • Brainsway
  • MagVenture
  • Yiruide
  • Neurosoft
  • Remed
  • Nexstim
  • MAG & More
  • Deymed

유형별 부문

  • 버터플라이 코일
  • 원형 코일
  • 기타

용도별 부문

  • sTMS
  • rTMS
  • 기타

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동 및 아프리카
LSH 25.12.02

자주 묻는 질문

  • 경두개 자기자극(TMS) 코일 시장 규모는 어떻게 예측되나요?
  • 경두개 자기자극(TMS) 코일의 주요 용도는 무엇인가요?
  • TMS 코일의 주요 기업은 어디인가요?
  • TMS 코일의 기술적 장벽은 무엇인가요?
  • TMS 코일의 시장 세분화는 어떻게 이루어지나요?

The global market for TMS (Transcranial Magnetic Stimulation) Coil was estimated to be worth US$ 29.9 million in 2024 and is forecast to a readjusted size of US$ 85.4 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on TMS (Transcranial Magnetic Stimulation) Coil cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

The Transcranial Magnetic Stimulation (TMS) Coil is the core component of TMS devices, responsible for generating rapidly changing magnetic fields that induce electric currents in cortical neurons to modulate brain activity non-invasively. Typically made from coiled conductive copper wire, TMS coils come in various forms such as figure-eight, circular, or H-shaped configurations, each offering different focality and stimulation depth. TMS Coils are widely used in psychiatric therapy (e.g., depression, anxiety), neurorehabilitation (e.g., post-stroke recovery, Parkinson's disease), and neuroscience research. As precision medicine, personalized therapies, and mental health demands grow, TMS coils are increasingly transitioning from academic labs into routine clinical settings, becoming a key technological enabler in next-generation neuromodulation systems.In 2024, global Transcranial Magnetic Stimulation (TMS) Coil production reached approximately 5688 unit, with an average global market price of around US$ 5270/unit.

With rising global prevalence of mental health disorders and increasing demand for non-pharmacological interventions, TMS technology is gaining strong momentum across clinical and research sectors. As the core component of TMS devices, coil performance and cost efficiency play a critical role in treatment outcomes and device adoption. The continuous launch of next-generation coils featuring deep brain stimulation and multi-channel targeting is expanding therapeutic applications beyond depression to Alzheimer's, autism, and chronic pain. Meanwhile, favorable reimbursement policies in developed markets like the US and EU are encouraging hospitals, psychiatric clinics, and rehabilitation centers to procure TMS devices, driving substantial upstream demand for coils.

As a converter of electromagnetic energy, the TMS coil faces high technical barriers due to its complex design, heat tolerance requirements, and challenges in ensuring production consistency. Globally, most TMS device manufacturers rely on in-house or closed-loop coil supply chains, limiting entry opportunities for independent coil vendors. Although TMS coils are high-usage consumables, their replacement cycles and usage standards vary widely, creating discrepancies between actual demand and market size estimates. Additionally, tightening medical device regulations worldwide present hurdles in terms of prolonged certification cycles and rigorous validation protocols.

Downstream applications of TMS are rapidly expanding from psychiatry (primarily major depressive disorder) to rehabilitation medicine, pain management, and pediatric neurological disorders. Patient-centric care models are driving demand for customized coil designs and individualized stimulation protocols, positioning these as key differentiators among device manufacturers. The emergence of portable and home-use TMS devices is fueling growth in compact and lightweight coil demand. New buyer segments such as research institutes, startups, and outpatient chains are reshaping the market landscape, unlocking new growth potential for TMS coil suppliers.

This report aims to provide a comprehensive presentation of the global market for TMS (Transcranial Magnetic Stimulation) Coil, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of TMS (Transcranial Magnetic Stimulation) Coil by region & country, by Type, and by Application.

The TMS (Transcranial Magnetic Stimulation) Coil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TMS (Transcranial Magnetic Stimulation) Coil.

Market Segmentation

By Company

  • Magstim
  • Neuronetics
  • Brainsway
  • MagVenture
  • Yiruide
  • Neurosoft
  • Remed
  • Nexstim
  • MAG & More
  • Deymed

Segment by Type

  • Butterfly Coil
  • Circular Coil
  • Others

Segment by Application

  • sTMS
  • rTMS
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of TMS (Transcranial Magnetic Stimulation) Coil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of TMS (Transcranial Magnetic Stimulation) Coil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of TMS (Transcranial Magnetic Stimulation) Coil in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 TMS (Transcranial Magnetic Stimulation) Coil Product Introduction
  • 1.2 Global TMS (Transcranial Magnetic Stimulation) Coil Market Size Forecast
    • 1.2.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value (2020-2031)
    • 1.2.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume (2020-2031)
    • 1.2.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Price (2020-2031)
  • 1.3 TMS (Transcranial Magnetic Stimulation) Coil Market Trends & Drivers
    • 1.3.1 TMS (Transcranial Magnetic Stimulation) Coil Industry Trends
    • 1.3.2 TMS (Transcranial Magnetic Stimulation) Coil Market Drivers & Opportunity
    • 1.3.3 TMS (Transcranial Magnetic Stimulation) Coil Market Challenges
    • 1.3.4 TMS (Transcranial Magnetic Stimulation) Coil Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global TMS (Transcranial Magnetic Stimulation) Coil Players Revenue Ranking (2024)
  • 2.2 Global TMS (Transcranial Magnetic Stimulation) Coil Revenue by Company (2020-2025)
  • 2.3 Global TMS (Transcranial Magnetic Stimulation) Coil Players Sales Volume Ranking (2024)
  • 2.4 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Company Players (2020-2025)
  • 2.5 Global TMS (Transcranial Magnetic Stimulation) Coil Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers TMS (Transcranial Magnetic Stimulation) Coil Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers TMS (Transcranial Magnetic Stimulation) Coil Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of TMS (Transcranial Magnetic Stimulation) Coil
  • 2.9 TMS (Transcranial Magnetic Stimulation) Coil Market Competitive Analysis
    • 2.9.1 TMS (Transcranial Magnetic Stimulation) Coil Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by TMS (Transcranial Magnetic Stimulation) Coil Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TMS (Transcranial Magnetic Stimulation) Coil as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Butterfly Coil
    • 3.1.2 Circular Coil
    • 3.1.3 Others
  • 3.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type
    • 3.2.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value, by Type (2020-2031)
    • 3.2.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value, by Type (%) (2020-2031)
  • 3.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Type
    • 3.3.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume, by Type (2020-2031)
    • 3.3.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global TMS (Transcranial Magnetic Stimulation) Coil Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 sTMS
    • 4.1.2 rTMS
    • 4.1.3 Others
  • 4.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application
    • 4.2.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value, by Application (2020-2031)
    • 4.2.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value, by Application (%) (2020-2031)
  • 4.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Application
    • 4.3.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume, by Application (2020-2031)
    • 4.3.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global TMS (Transcranial Magnetic Stimulation) Coil Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Region
    • 5.1.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Region (2020-2025)
    • 5.1.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Region (2026-2031)
    • 5.1.4 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Region (%), (2020-2031)
  • 5.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Region
    • 5.2.1 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Region (2020-2025)
    • 5.2.3 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Region (2026-2031)
    • 5.2.4 Global TMS (Transcranial Magnetic Stimulation) Coil Sales Volume by Region (%), (2020-2031)
  • 5.3 Global TMS (Transcranial Magnetic Stimulation) Coil Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 5.4.2 North America TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 5.5.2 Europe TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 5.6.2 Asia Pacific TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 5.7.2 South America TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions TMS (Transcranial Magnetic Stimulation) Coil Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions TMS (Transcranial Magnetic Stimulation) Coil Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions TMS (Transcranial Magnetic Stimulation) Coil Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.3.2 United States TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.4.2 Europe TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.5.2 China TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.6.2 Japan TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.7.2 South Korea TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.8.2 Southeast Asia TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India TMS (Transcranial Magnetic Stimulation) Coil Sales Value, 2020-2031
    • 6.9.2 India TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India TMS (Transcranial Magnetic Stimulation) Coil Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Magstim
    • 7.1.1 Magstim Company Information
    • 7.1.2 Magstim Introduction and Business Overview
    • 7.1.3 Magstim TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Magstim TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.1.5 Magstim Recent Development
  • 7.2 Neuronetics
    • 7.2.1 Neuronetics Company Information
    • 7.2.2 Neuronetics Introduction and Business Overview
    • 7.2.3 Neuronetics TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Neuronetics TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.2.5 Neuronetics Recent Development
  • 7.3 Brainsway
    • 7.3.1 Brainsway Company Information
    • 7.3.2 Brainsway Introduction and Business Overview
    • 7.3.3 Brainsway TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Brainsway TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.3.5 Brainsway Recent Development
  • 7.4 MagVenture
    • 7.4.1 MagVenture Company Information
    • 7.4.2 MagVenture Introduction and Business Overview
    • 7.4.3 MagVenture TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 MagVenture TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.4.5 MagVenture Recent Development
  • 7.5 Yiruide
    • 7.5.1 Yiruide Company Information
    • 7.5.2 Yiruide Introduction and Business Overview
    • 7.5.3 Yiruide TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Yiruide TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.5.5 Yiruide Recent Development
  • 7.6 Neurosoft
    • 7.6.1 Neurosoft Company Information
    • 7.6.2 Neurosoft Introduction and Business Overview
    • 7.6.3 Neurosoft TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Neurosoft TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.6.5 Neurosoft Recent Development
  • 7.7 Remed
    • 7.7.1 Remed Company Information
    • 7.7.2 Remed Introduction and Business Overview
    • 7.7.3 Remed TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Remed TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.7.5 Remed Recent Development
  • 7.8 Nexstim
    • 7.8.1 Nexstim Company Information
    • 7.8.2 Nexstim Introduction and Business Overview
    • 7.8.3 Nexstim TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Nexstim TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.8.5 Nexstim Recent Development
  • 7.9 MAG & More
    • 7.9.1 MAG & More Company Information
    • 7.9.2 MAG & More Introduction and Business Overview
    • 7.9.3 MAG & More TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 MAG & More TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.9.5 MAG & More Recent Development
  • 7.10 Deymed
    • 7.10.1 Deymed Company Information
    • 7.10.2 Deymed Introduction and Business Overview
    • 7.10.3 Deymed TMS (Transcranial Magnetic Stimulation) Coil Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Deymed TMS (Transcranial Magnetic Stimulation) Coil Product Offerings
    • 7.10.5 Deymed Recent Development

8 Industry Chain Analysis

  • 8.1 TMS (Transcranial Magnetic Stimulation) Coil Industrial Chain
  • 8.2 TMS (Transcranial Magnetic Stimulation) Coil Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 TMS (Transcranial Magnetic Stimulation) Coil Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 TMS (Transcranial Magnetic Stimulation) Coil Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제